This guide helps you evaluate what a UK peptide clinic publicly says about itself — and identify what is not said. It is a decision-support tool, not a clinical recommendation or regulatory opinion. Always consult a qualified medical professional before making any health decision.
For worked examples, open the reference profiles in Clinics: each applies the same “stated / not stated” discipline and links to registers you can check yourself.
A lot of people land here after searching for semaglutide, tirzepatide, Mounjaro, private providers, or whether NHS access is realistic. If your first problem is route choice rather than clinic comparison, read How to get semaglutide or tirzepatide in the UK safely first, then come back to this checklist once you are comparing actual providers.
Start with what is publicly stated
The fastest way to assess a UK peptide clinic is to look carefully at what it publicly states about its care model. A clinic that cannot clearly answer these questions on its public website is giving you less to work with before you commit time or money.
The checklist below does not judge clinical quality — it identifies what the clinic has and has not chosen to make transparent.
1. Clinical oversight
A responsible peptide-related clinic should be able to clearly describe who is clinically responsible for the service.
- Does the clinic publicly name a medical director, lead doctor, or prescribing clinician?
- Can you verify that named clinician on the GMC medical register?
- Does the clinic describe who makes prescribing decisions (where a prescription is involved)?
- Is the clinical oversight model clear — or does the website describe only the service, not the team?
Prescription-only medicines — which may be involved in peptide therapy — require a UK-registered prescriber. Clinics that do not publicly identify who prescribes, or rely on vague "clinical team" language, offer you less information to work with when making your decision.
2. Consultation and assessment process
A clinic that takes clinical responsibility seriously will typically describe its assessment process before treatment begins.
- Does the clinic describe what happens at an initial consultation?
- Is it clear whether the consultation is in-person, remote, or both?
- Does the clinic describe what health information is reviewed before a programme begins?
- Is any baseline testing (bloodwork, diagnostics) mentioned as part of the process?
- Is contraindication screening — i.e. checking for reasons not to proceed — mentioned?
3. Monitoring and follow-up
Ongoing monitoring is a meaningful signal in the care model description.
- Does the clinic describe how progress is reviewed during a programme?
- Is there a described process for ongoing clinician contact or check-ins?
- Is repeat testing or monitoring mentioned as part of longer programmes?
- Is there a clear process for raising concerns or adjusting the programme?
4. Regulatory and governance context
Where regulation applies, it should be clear from the clinic's public materials.
- Does the clinic reference its CQC registration where relevant? (CQC applies to many — but not all — private clinic types in England)
- Can you find the clinic in the CQC Find Care search?
- Does the clinic describe how complaints or clinical concerns are handled?
- Is the clinic's registered business name and address clearly stated?
Not all private clinics are required to register with the CQC — it depends on the regulated activities they carry out. However, if a clinic offers services that would typically require CQC registration (such as treatment, assessment, or diagnosis), you should expect to be able to verify their status on the CQC register. If you cannot, that is worth investigating before proceeding.
5. Transparency signals
Beyond the specifics above, general transparency is a useful proxy.
- Are clinic pricing and programme structures clearly described — or is "contact us for a price" the only option?
- Does the clinic describe what is included in a programme versus what costs extra?
- Are terms, cancellation policies, or patient rights described somewhere public?
- Does the clinic link to or reference relevant UK authority sources (CQC, MHRA, NHS)?
- Does the clinic describe any limitations of its services — what it does not treat or assess?
Questions to ask before booking
If you contact a clinic before booking, these questions are reasonable to ask directly:
Who will be responsible for my care — and can I verify their GMC registration?
A reputable clinic should be able to name the clinician responsible for your care and confirm their professional registration. You can verify GMC registration at gmc-uk.org.
What does the initial consultation involve, and what will be assessed?
A well-run clinic should be able to describe what happens at the consultation — your medical history, any testing, what the clinician will review, and how a decision to proceed will be made. If this information is not readily available, ask before paying for anything.
Is any baseline testing or bloodwork involved?
For many peptide-related services, baseline testing — including bloodwork — is a reasonable part of an initial assessment. Not all clinics include this. Ask whether it is included, optional, or not part of the process at all.
Is the clinic registered with the CQC?
If the clinic carries out regulated activities in England, it should be registered with the Care Quality Commission. You can search the CQC Find Care register. If the clinic is not CQC-registered, ask why — it may be a legitimate exemption, or it may be worth investigating further.
How is my progress monitored, and who do I contact if something changes?
You should know in advance how progress is reviewed, how often, and who to contact if you have a concern during a programme. Clinics that are vague about follow-up processes are giving you less certainty about ongoing support.
What if one provider asks for more checks or documents than another?
That is not automatically a bad sign. Sometimes it reflects a stricter prescribing or continuity process. The useful question is whether the provider can explain clearly what they are checking and why. Extra checks with a coherent clinical explanation are very different from vague demands that are hard to justify.
Red flags to watch for
These are not definitive proof of a problem — but they are signals that warrant more scrutiny:
- No named clinician or medical lead publicly identified
- No description of initial consultation or assessment process
- Outcome guarantees or unverifiable claims in the service description
- No CQC reference where you would expect one
- No clear process for questions, complaints, or concerns during treatment
- Prices or programme details only available after you have provided your contact details
Further resources
- CQC Find Care — search for regulated health and social care providers in England
- GMC Medical Register — verify a doctor's registration status
- GPhC registers — verify pharmacist and pharmacy (premises) registration where relevant
- NHS — hospitals and services — overview of NHS hospital services (general context when comparing NHS and private care routes)